Parkinson disease: Calcium channel blockers and Parkinson disease

Nature Reviews Neurology

Volumn 6, Issue 4, 2010, Pages 188-189

  Pfeiffer, Ronald F ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DIHYDROPYRIDINE; DILTIAZEM; ISRADIPINE; PRION PROTEIN; RASAGILINE; REACTIVE OXYGEN METABOLITE; VERAPAMIL;

CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CLINICAL TRIAL; DOPAMINERGIC NERVE CELL; DRUG PENETRATION; DRUG PROTEIN BINDING; ENERGY EXPENDITURE; FACILITATION; HUMAN; NEUROPATHOLOGY; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RISK REDUCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

CALCIUM CHANNEL BLOCKERS; HUMANS; PARKINSON DISEASE;

EID: 77950842097     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.31     Document Type: Short Survey

References (9)

1. Olanow, w. C. et al. A double-blind, delayedstart trial of rasagiline in Parkinson's disease. N. Engl. J. Med. 361, 1268-1278 (2009).
2. wider, C. & wszolek, Z. K. Clinical genetics of Parkinson's disease and related disorders. Parkinsonism Relat. Disord. 13 (suppl. 3), s229-s232 (2007).
3. Tanner, C. M. et al. Occupation and risk of parkinsonism: a multicenter case-control study. Arch. Neurol. 66, 1106-1113 (2009).
4. DeCuypere, M., Lu, Y., Miller, D. D. & LeDoux, M. s. Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain. J. Neurochem. 107, 1398-1413 (2008).
5. Olanow, w. C. & Prusiner, s. B. is Parkinson's disease a prion disorder? Proc. Natl Acad. Sci. USA 106, 12571-12572 (2009).
6. Jang, H. et al. Highly pathogenic H5n1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc. Natl Acad. Sci. USA 106, 14063-14068 (2009).
7. Ritz, B. et al. L-type calcium channel blockers and Parkinson's disease in Denmark. Ann. Neurol. doi: 10.1002/ana.21937.
8. surmeier, D. J., Guzman, J. n. & sanchez-Padilla, J. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease. Cell Calcium doi:10.1016/j.ceca.2009.12.003.
9. Guzman, J. n., sanchez-Padilla, J., Chan, C. s. & surmeier, D. J. Robust pacemaking in substantia nigra dopaminergic neurons. J. Neurosci. 29, 11011-11019 (2009).